米国のコンピュータ支援検出(CAD)市場-2031年までの産業動向と予測U.S. Computer Aided Detection (CAD) Market - Industry Trends and Forecast to 2031 米国のCAD(Computer Aided Detection)市場は、2023年の7億4,232万米ドルから2031年には18億2,695万米ドルに達すると予測され、2024年から2031年の予測期間において年平均成長率12.0%で成長すると予測される。 ... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー米国のCAD(Computer Aided Detection)市場は、2023年の7億4,232万米ドルから2031年には18億2,695万米ドルに達すると予測され、2024年から2031年の予測期間において年平均成長率12.0%で成長すると予測される。市場区分 米国コンピュータ支援検出(CAD)市場:製品タイプ別(ソフトウェアとサービス)、画像モダリティ別(乳房画像診断、肺画像診断、腫瘍学と放射線、腹部と骨盤画像診断、歯科画像診断、心臓血管画像診断、その他)、用途別(癌、神経疾患, 心血管系疾患, 筋骨格系疾患, その他), 購入形態 (団体購入, 個人), エンドユーザー (病院, 診断センター, 研究センター, 学術機関, その他), 国 (米国) - 産業動向は以下の通り。米国) - 産業動向と2031年までの予測 米国のコンピュータ支援検出(CAD)市場ダイナミクスの概要 促進要因 - 医療分野におけるコンピュータ支援検出(CAD)システムの用途拡大 抑制要因 - コンピュータ支援検出(CAD)システムの高コスト 機会 - 米国の先進医療インフラ 市場プレイヤー 米国のコンピュータ支援検出(CAD)市場で事業を展開する主な市場参入企業は以下の通り: - Koninklijke Philips N.V. - 富士フイルムホールディングス - キャノンメディカルシステムズ株式会社 - シーメンスヘルスケア - メディアンテクノロジーズ - ゼネラル・エレクトリック社 - ホロジック社 - iCAD社 - EDDAテクノロジー社 - リバレイン・テクノロジーズ 目次TABLE OF CONTENTS 1 INTRODUCTION 13 1.1 OBJECTIVES OF THE STUDY 13 1.2 MARKET DEFINITION 13 1.3 OVERVIEW OF THE U.S. COMPUTER AIDED DETECTION (CAD) MARKET 13 1.4 CURRENCY AND PRICING 14 1.5 LIMITATIONS 14 1.6 MARKETS COVERED 15 2 MARKET SEGMENTATION 18 2.1 MARKETS COVERED 18 2.2 GEOGRAPHICAL SCOPE 19 2.3 YEARS CONSIDERED FOR THE STUDY 19 2.4 DBMR TRIPOD DATA VALIDATION MODEL 20 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 23 2.6 DBMR MARKET POSITION GRID 24 2.7 MULTIVARIATE MODELLING 25 2.8 TYPE LIFELINE CURVE 25 2.9 MARKET END USER COVERAGE GRID 26 2.10 SECONDARY SOURCES 27 2.11 ASSUMPTIONS 27 3 EXECUTIVE SUMMARY 28 4 PREMIUM INSIGHTS 30 4.1 PESTEL ANALYSIS 31 4.2 PORTER’S FIVE FORCES 32 5 MARKET OVERVIEW 33 5.1 DRIVERS 35 5.1.1 RISING APPLICATION OF COMPUTER-AIDED DETECTION (CAD) SYSTEMS IN THE MEDICAL FIELD 35 5.1.2 INCREASING TECHNOLOGICAL ADVANCEMENTS ASSOCIATED WITH CAD 35 5.1.3 GOVERNMENT INITIATIVES FOR COMPUTER AIDED DETECTION (CAD) SYSTEMS 36 5.2 RESTRAINTS 37 5.2.1 HIGH COST OF COMPUTER AIDED DETECTION (CAD) SYSTEMS 37 5.2.2 STRICT GUIDELINES FOR COMPUTER AIDED DETECTION (CAD) 38 5.3 OPPORTUNITIES 39 5.3.1 ADVANCED HEALTHCARE INFRASTRUCTURE OF THE COUNTRIES 39 5.3.2 INCREASING AWARENESS REGARDING ACCURATE DIAGNOSIS 39 5.4 CHALLENGE 40 5.4.1 DEPENDENCY ON SKILLED MEDICAL PROFESSIONALS 40 6 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE 41 6.1 OVERVIEW 42 6.2 SOFTWARE 45 6.2.1 INTEGRATED CAD 45 6.2.1.1 CLOUD-BASED 45 6.2.1.2 ON-PREMISES 45 6.2.2 STANDALONE CAD 45 6.2.2.1 CLOUD-BASED 46 6.2.2.2 ON-PREMISES 46 6.3 SERVICES 46 7 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY 47 7.1 OVERVIEW 48 7.2 ONCOLOGY AND RADIATION 51 7.2.1 BY TYPE 51 7.2.1.1 ONCOLOGY CAD 51 7.2.1.2 RADIATION THERAPY PLANNING 51 7.2.2 BY TUMOR TYPE 51 7.2.2.1 MALIGNANT 51 7.2.2.2 BENIGN 52 7.2.3 BY PRODUCT TYPE 52 7.2.3.1 SOFTWARE 52 7.2.3.2 SERVICES 52 7.3 BREAST IMAGING 52 7.3.1 BY TYPE 52 7.3.1.1 MAMMOGRAPHY CAD 52 7.3.1.2 BREAST ULTRASOUND CAD 53 7.3.2 BY PRODUCT TYPE 53 7.3.2.1 SOFTWARE 53 7.3.2.2 SERVICES 53 7.4 LUNG IMAGING 53 7.4.1 BY TYPE 53 7.4.1.1 CHEST X-RAY CAD 54 7.4.1.2 CHEST CT CAD ON PULMONARY NODULES 54 7.4.2 BY NODULE SIZE 54 7.4.2.1 >4MM AND <5MM 54 7.4.2.2 >5MM 54 7.4.2.3 3 MM AND < 4MM 54 7.4.3 BY NODULE 55 7.4.3.1 PART SOLID NODULES 55 7.4.3.2 NON- SOLID NODULES 55 7.4.4 BY NODULE TYPE 55 7.4.4.1 JUXTAPLEURAL NODULES 55 7.4.4.2 ISOLATED NODULES 55 7.4.4.3 GROUND-GLASS NODULES 56 7.4.5 BY PRODUCT TYPE 56 7.4.5.1 SOFTWARE 56 7.4.5.2 SERVICES 56 7.5 CARDIOVASCULAR IMAGING 56 7.5.1 BY TYPE 56 7.5.1.1 CARDIAC CT CAD 56 7.5.1.2 CARDIAC MRI CAD 57 7.5.2 BY PRODUCT TYPE 57 7.5.2.1 SOFTWARE 57 7.5.2.2 SERVICES 57 7.6 ABDOMINAL AND PELVIC IMAGING 57 7.6.1 BY TYPE 57 7.6.1.1 GASTROINTESTINAL CAD 58 7.6.1.2 ABDOMINAL CT CAD 58 7.6.1.3 KIDNEY CAD 58 7.6.2 BY PRODUCT TYPE 58 7.6.2.1 SOFTWARE 58 7.6.2.2 SERVICES 58 7.6.2.3 DENTAL IMAGING 58 7.6.3 BY PRODUCT TYPE 59 7.6.3.1 SOFTWARE 59 7.6.3.2 SERVICES 59 7.7 OTHERS 59 8 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION 60 8.1 OVERVIEW 61 8.2 CANCER 64 8.2.1 BREAST CANCER 64 8.2.2 COLORECTAL CANCER 64 8.2.3 LUNG CANCER 64 8.2.4 PROSTATE CANCER 64 8.2.5 LIVER CANCER 64 8.2.6 BONE CANCER 65 8.2.7 OTHERS 65 8.2.7.1 SOFTWARE 65 8.2.7.2 SERVICES 65 8.3 NEUROLOGICAL DISORDERS 65 8.3.1 MULTIPLE SCLEROSIS 66 8.3.2 STROKE 66 8.3.3 OTHERS 66 8.3.3.1 SOFTWARE 66 8.3.3.2 SERVICES 66 8.4 CARDIOVASCULAR DISEASES 67 8.4.1 CORONARY ARTERY DISEASE 67 8.4.2 CONGENITAL HEART DEFECTS 67 8.4.3 VALVULAR HEART DISEASE 67 8.4.4 OTHERS 68 8.4.4.1 SOFTWARE 68 8.4.4.2 SERVICES 68 8.5 MUSCULOSKELETAL DISEASES 68 8.5.1 OSTEOARTHRITIS 69 8.5.2 RHEUMATOID ARTHRITIS 69 8.5.3 JOINT DISORDERS 69 8.5.4 OTHERS 69 8.5.4.1 SOFTWARE 69 8.5.4.2 SERVICES 69 8.6 OTHERS 69 9 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE 70 9.1 OVERVIEW 71 9.2 GROUP PURCHASE ORGANIZATIONS 74 9.3 INDIVIDUAL 74 10 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER 75 10.1 OVERVIEW 76 10.2 HOSPITALS 79 10.2.1 PRIVATE 79 10.2.2 PUBLIC 79 10.3 DIAGNOSTIC CENTERS 79 10.4 RESEARCH CENTERS & ACADEMIC INSTITUTES 79 10.5 OTHERS 79 11 COMPANY LANDSCAPE 80 11.1 COMPANY SHARE ANALYSIS: U.S. 80 12 SWOT ANALYSIS 81 13 COMPANY PROFILES 82 13.1 FUJIFILM HOLDINGS CORPORATION 82 13.1.1 COMPANY SNAPSHOT 82 13.1.2 REVENUE ANALYSIS 82 13.1.3 PRODUCT PORTFOLIO 83 13.1.4 RECENT DEVELOPMENT 83 13.2 KONINKLIJKE PHILIPS N.V. 84 13.2.1 COMPANY SNAPSHOT 84 13.2.2 REVENUE ANALYSIS 84 13.2.3 PRODUCT PORTFOLIO 85 13.2.4 RECENT DEVELOPMENT 85 13.3 CANON MEDICAL SYSTEMS CORPORATION 86 13.3.1 COMPANY SNAPSHOT 86 13.3.2 REVENUE ANALYSIS 86 13.3.3 PRODUCT PORTFOLIO 87 13.3.4 RECENT DEVELOPMENT 87 13.4 SIEMENS HEALTHINEERS AG 88 13.4.1 COMPANY SNAPSHOT 88 13.4.2 REVENUE ANALYSIS 88 13.4.3 PRODUCT PORTFOLIO 88 13.4.4 RECENT DEVELOPMENT 89 13.5 MEDIAN TECHNOLOGIES. 90 13.5.1 COMPANY SNAPSHOT 90 13.5.2 REVENUE ANALYSIS 90 13.5.3 PRODUCT PORTFOLIO 91 13.5.4 RECENT DEVELOPMENT 91 13.6 GENERAL ELECTRIC 92 13.6.1 COMPANY SNAPSHOT 92 13.6.2 REVENUE ANALYSIS 92 13.6.3 PRODUCT PORTFOLIO 92 13.6.4 RECENT DEVELOPMENT 93 13.7 HOLOGIC INC. 94 13.7.1 COMPANY SNAPSHOT 94 13.7.2 REVENUE ANALYSIS 94 13.7.3 PRODUCT PORTFOLIO 94 13.7.4 RECENT DEVELOPMENT 95 13.8 ICAD, INC. 96 13.8.1 COMPANY SNAPSHOT 96 13.8.2 REVENUE ANALYSIS 96 13.8.3 PRODUCT PORTFOLIO 97 13.8.4 RECENT DEVELOPMENT 97 13.9 EDDA TECHNOLOGY, INC. 98 13.9.1 COMPANY SNAPSHOT 98 13.9.2 PRODUCT PORTFOLIO 98 13.9.3 RECENT DEVELOPMENT 98 13.10 RIVERAIN TECHNOLOGIES 99 13.10.1 COMPANY SNAPSHOT 99 13.10.2 PRODUCT PORTFOLIO 99 13.10.3 RECENT DEVELOPMENT 99 14 QUESTIONNAIRE 100 15 RELATED REPORTS 103
SummaryThe U.S. Computer Aided Detection (CAD) market is expected to reach USD 1,826.95 million by 2031 from USD 742.32 million in 2023, growing with a CAGR of 12.0% in the forecast period of 2024 to 2031. Table of ContentsTABLE OF CONTENTS 1 INTRODUCTION 13 1.1 OBJECTIVES OF THE STUDY 13 1.2 MARKET DEFINITION 13 1.3 OVERVIEW OF THE U.S. COMPUTER AIDED DETECTION (CAD) MARKET 13 1.4 CURRENCY AND PRICING 14 1.5 LIMITATIONS 14 1.6 MARKETS COVERED 15 2 MARKET SEGMENTATION 18 2.1 MARKETS COVERED 18 2.2 GEOGRAPHICAL SCOPE 19 2.3 YEARS CONSIDERED FOR THE STUDY 19 2.4 DBMR TRIPOD DATA VALIDATION MODEL 20 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 23 2.6 DBMR MARKET POSITION GRID 24 2.7 MULTIVARIATE MODELLING 25 2.8 TYPE LIFELINE CURVE 25 2.9 MARKET END USER COVERAGE GRID 26 2.10 SECONDARY SOURCES 27 2.11 ASSUMPTIONS 27 3 EXECUTIVE SUMMARY 28 4 PREMIUM INSIGHTS 30 4.1 PESTEL ANALYSIS 31 4.2 PORTER’S FIVE FORCES 32 5 MARKET OVERVIEW 33 5.1 DRIVERS 35 5.1.1 RISING APPLICATION OF COMPUTER-AIDED DETECTION (CAD) SYSTEMS IN THE MEDICAL FIELD 35 5.1.2 INCREASING TECHNOLOGICAL ADVANCEMENTS ASSOCIATED WITH CAD 35 5.1.3 GOVERNMENT INITIATIVES FOR COMPUTER AIDED DETECTION (CAD) SYSTEMS 36 5.2 RESTRAINTS 37 5.2.1 HIGH COST OF COMPUTER AIDED DETECTION (CAD) SYSTEMS 37 5.2.2 STRICT GUIDELINES FOR COMPUTER AIDED DETECTION (CAD) 38 5.3 OPPORTUNITIES 39 5.3.1 ADVANCED HEALTHCARE INFRASTRUCTURE OF THE COUNTRIES 39 5.3.2 INCREASING AWARENESS REGARDING ACCURATE DIAGNOSIS 39 5.4 CHALLENGE 40 5.4.1 DEPENDENCY ON SKILLED MEDICAL PROFESSIONALS 40 6 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY PRODUCT TYPE 41 6.1 OVERVIEW 42 6.2 SOFTWARE 45 6.2.1 INTEGRATED CAD 45 6.2.1.1 CLOUD-BASED 45 6.2.1.2 ON-PREMISES 45 6.2.2 STANDALONE CAD 45 6.2.2.1 CLOUD-BASED 46 6.2.2.2 ON-PREMISES 46 6.3 SERVICES 46 7 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY IMAGING MODALITY 47 7.1 OVERVIEW 48 7.2 ONCOLOGY AND RADIATION 51 7.2.1 BY TYPE 51 7.2.1.1 ONCOLOGY CAD 51 7.2.1.2 RADIATION THERAPY PLANNING 51 7.2.2 BY TUMOR TYPE 51 7.2.2.1 MALIGNANT 51 7.2.2.2 BENIGN 52 7.2.3 BY PRODUCT TYPE 52 7.2.3.1 SOFTWARE 52 7.2.3.2 SERVICES 52 7.3 BREAST IMAGING 52 7.3.1 BY TYPE 52 7.3.1.1 MAMMOGRAPHY CAD 52 7.3.1.2 BREAST ULTRASOUND CAD 53 7.3.2 BY PRODUCT TYPE 53 7.3.2.1 SOFTWARE 53 7.3.2.2 SERVICES 53 7.4 LUNG IMAGING 53 7.4.1 BY TYPE 53 7.4.1.1 CHEST X-RAY CAD 54 7.4.1.2 CHEST CT CAD ON PULMONARY NODULES 54 7.4.2 BY NODULE SIZE 54 7.4.2.1 >4MM AND <5MM 54 7.4.2.2 >5MM 54 7.4.2.3 3 MM AND < 4MM 54 7.4.3 BY NODULE 55 7.4.3.1 PART SOLID NODULES 55 7.4.3.2 NON- SOLID NODULES 55 7.4.4 BY NODULE TYPE 55 7.4.4.1 JUXTAPLEURAL NODULES 55 7.4.4.2 ISOLATED NODULES 55 7.4.4.3 GROUND-GLASS NODULES 56 7.4.5 BY PRODUCT TYPE 56 7.4.5.1 SOFTWARE 56 7.4.5.2 SERVICES 56 7.5 CARDIOVASCULAR IMAGING 56 7.5.1 BY TYPE 56 7.5.1.1 CARDIAC CT CAD 56 7.5.1.2 CARDIAC MRI CAD 57 7.5.2 BY PRODUCT TYPE 57 7.5.2.1 SOFTWARE 57 7.5.2.2 SERVICES 57 7.6 ABDOMINAL AND PELVIC IMAGING 57 7.6.1 BY TYPE 57 7.6.1.1 GASTROINTESTINAL CAD 58 7.6.1.2 ABDOMINAL CT CAD 58 7.6.1.3 KIDNEY CAD 58 7.6.2 BY PRODUCT TYPE 58 7.6.2.1 SOFTWARE 58 7.6.2.2 SERVICES 58 7.6.2.3 DENTAL IMAGING 58 7.6.3 BY PRODUCT TYPE 59 7.6.3.1 SOFTWARE 59 7.6.3.2 SERVICES 59 7.7 OTHERS 59 8 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY APPLICATION 60 8.1 OVERVIEW 61 8.2 CANCER 64 8.2.1 BREAST CANCER 64 8.2.2 COLORECTAL CANCER 64 8.2.3 LUNG CANCER 64 8.2.4 PROSTATE CANCER 64 8.2.5 LIVER CANCER 64 8.2.6 BONE CANCER 65 8.2.7 OTHERS 65 8.2.7.1 SOFTWARE 65 8.2.7.2 SERVICES 65 8.3 NEUROLOGICAL DISORDERS 65 8.3.1 MULTIPLE SCLEROSIS 66 8.3.2 STROKE 66 8.3.3 OTHERS 66 8.3.3.1 SOFTWARE 66 8.3.3.2 SERVICES 66 8.4 CARDIOVASCULAR DISEASES 67 8.4.1 CORONARY ARTERY DISEASE 67 8.4.2 CONGENITAL HEART DEFECTS 67 8.4.3 VALVULAR HEART DISEASE 67 8.4.4 OTHERS 68 8.4.4.1 SOFTWARE 68 8.4.4.2 SERVICES 68 8.5 MUSCULOSKELETAL DISEASES 68 8.5.1 OSTEOARTHRITIS 69 8.5.2 RHEUMATOID ARTHRITIS 69 8.5.3 JOINT DISORDERS 69 8.5.4 OTHERS 69 8.5.4.1 SOFTWARE 69 8.5.4.2 SERVICES 69 8.6 OTHERS 69 9 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY MODE OF PURCHASE 70 9.1 OVERVIEW 71 9.2 GROUP PURCHASE ORGANIZATIONS 74 9.3 INDIVIDUAL 74 10 U.S. COMPUTER AIDED DETECTION (CAD) MARKET, BY END USER 75 10.1 OVERVIEW 76 10.2 HOSPITALS 79 10.2.1 PRIVATE 79 10.2.2 PUBLIC 79 10.3 DIAGNOSTIC CENTERS 79 10.4 RESEARCH CENTERS & ACADEMIC INSTITUTES 79 10.5 OTHERS 79 11 COMPANY LANDSCAPE 80 11.1 COMPANY SHARE ANALYSIS: U.S. 80 12 SWOT ANALYSIS 81 13 COMPANY PROFILES 82 13.1 FUJIFILM HOLDINGS CORPORATION 82 13.1.1 COMPANY SNAPSHOT 82 13.1.2 REVENUE ANALYSIS 82 13.1.3 PRODUCT PORTFOLIO 83 13.1.4 RECENT DEVELOPMENT 83 13.2 KONINKLIJKE PHILIPS N.V. 84 13.2.1 COMPANY SNAPSHOT 84 13.2.2 REVENUE ANALYSIS 84 13.2.3 PRODUCT PORTFOLIO 85 13.2.4 RECENT DEVELOPMENT 85 13.3 CANON MEDICAL SYSTEMS CORPORATION 86 13.3.1 COMPANY SNAPSHOT 86 13.3.2 REVENUE ANALYSIS 86 13.3.3 PRODUCT PORTFOLIO 87 13.3.4 RECENT DEVELOPMENT 87 13.4 SIEMENS HEALTHINEERS AG 88 13.4.1 COMPANY SNAPSHOT 88 13.4.2 REVENUE ANALYSIS 88 13.4.3 PRODUCT PORTFOLIO 88 13.4.4 RECENT DEVELOPMENT 89 13.5 MEDIAN TECHNOLOGIES. 90 13.5.1 COMPANY SNAPSHOT 90 13.5.2 REVENUE ANALYSIS 90 13.5.3 PRODUCT PORTFOLIO 91 13.5.4 RECENT DEVELOPMENT 91 13.6 GENERAL ELECTRIC 92 13.6.1 COMPANY SNAPSHOT 92 13.6.2 REVENUE ANALYSIS 92 13.6.3 PRODUCT PORTFOLIO 92 13.6.4 RECENT DEVELOPMENT 93 13.7 HOLOGIC INC. 94 13.7.1 COMPANY SNAPSHOT 94 13.7.2 REVENUE ANALYSIS 94 13.7.3 PRODUCT PORTFOLIO 94 13.7.4 RECENT DEVELOPMENT 95 13.8 ICAD, INC. 96 13.8.1 COMPANY SNAPSHOT 96 13.8.2 REVENUE ANALYSIS 96 13.8.3 PRODUCT PORTFOLIO 97 13.8.4 RECENT DEVELOPMENT 97 13.9 EDDA TECHNOLOGY, INC. 98 13.9.1 COMPANY SNAPSHOT 98 13.9.2 PRODUCT PORTFOLIO 98 13.9.3 RECENT DEVELOPMENT 98 13.10 RIVERAIN TECHNOLOGIES 99 13.10.1 COMPANY SNAPSHOT 99 13.10.2 PRODUCT PORTFOLIO 99 13.10.3 RECENT DEVELOPMENT 99 14 QUESTIONNAIRE 100 15 RELATED REPORTS 103
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療機器)の最新刊レポート
Data Bridge Market Research社の医療デバイス分野での最新刊レポート
本レポートと同じKEY WORD(computer)の最新刊レポート
よくあるご質問Data Bridge Market Research社はどのような調査会社ですか?データブリッジマーケットリサーチ(Data Bridge Market Research)は500名以上の多様な分野のアナリストが所属するインドの調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/21 10:26 156.13 円 165.08 円 200.38 円 |